Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | February 26, 2019 | February 27, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date February 26, 2019 · Filed February 27, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 42,004 |
Reported balance
After 2019-02-26 transaction · row 1
1 source rowRow 1 · 2019-02-26 · Sale · Disposed 10,087 · Balance 42,004 F1: On February 26, 2019, Mr. Bernacchi sold an aggregate of 10,087 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $177.90 to $177.99 and $178.01 to $178.13. The Company maintains a record of the transactions and copies will be provided upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 26, 2019, Mr. Bernacchi sold an aggregate of 10,087 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $177.90 to $177.99 and $178.01 to $178.13. The Company maintains a record of the transactions and copies will be provided upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2019 Filed Feb 27, 2019 14:42 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 10,087 | $177.94 | $1,794,880.78 |
DisclosureSEC source: 0001156375-19-000007 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,004 F1 · price: On February 26, 2019, Mr. Bernacchi sold an aggregate of 10,087 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $177.90 to $177.99 and $178.01 to $178.13. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:04 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000102 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,091 F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 18:07 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 4,976 | $176.60 | $878,761.60 |
DisclosureSEC source: 0001156375-18-000086 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,004 F1 · price: On September 4, 2018 Mr. Bernacchi sold an aggregate of 4,976 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price range was $176.56 to$176.60. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 17:38 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000056 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,980 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| May 22, 2018 Filed May 22, 2018 21:37 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,228 | $160.75 | $358,151.00 |
DisclosureSEC source: 0001156375-18-000049 · edgardoc.xml · nonDerivative · entry 2 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,379 Read SEC document |
| May 21, 2018 Filed May 22, 2018 21:37 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,587 | $161.45 | $256,221.15 |
DisclosureSEC source: 0001156375-18-000049 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,607 Read SEC document |
| November 30, 2017 Filed Nov 30, 2017 22:26 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,501 | $149.75 | $224,774.75 |
DisclosureSEC source: 0001156375-17-000116 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,194 F1 · price: On November 30, 2017, Mr. Bernacchi sold an aggregate of 1,501 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $149.67 to $149.77. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:02 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000076 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 15:31 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 5,187 | $107.70 | $558,639.90 |
DisclosureSEC source: 0001156375-16-000209 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,886 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.